SCHEMBL5740955

SCHEMBL5740955

COc1ccc(-c2cc(Nc3ccc4nc(-c5cccc(C(F)(F)F)c5)cc(N)c4c3)nc(N)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 7/20 0.51
ABCG2 Q9UNQ0 1/20 0.48
MAPT P10636 4/20 0.46
TP53 P04637 2/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ACHE P22303 1/20 0.44
MCHR1 Q99705 1/20 0.44
LMNA P02545 1/20 0.43
RUVBL1 Q9Y265 1/20 0.43
AGPAT2 O15120 1/20 0.42
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5741057 0.92 ACP1 (0.57) ACP1MAPTTP53HPGDALOX15
SCHEMBL5741066 0.91 ACP1 (0.51) ACP1ABCG2MAPTTP53HPGD
SCHEMBL5742700 0.91 MCHR1 (0.52) ACP1ABCG2MAPTMCHR1LMNA
SCHEMBL5741286 0.89 MAPT (0.53) ACP1ABCG2MAPTTP53HPGD
SCHEMBL5742142 0.89 MAPT (0.57) ACP1MAPTTP53HPGDALOX15
SCHEMBL5741862 0.88 AGPAT2 (0.57) ABCG2MAPTTP53HSD17B10KDM4E
SCHEMBL5743423 0.88 MAPT (0.48) ACP1ABCG2MAPTTP53HPGD
SCHEMBL5743353 0.88 RAB9A (0.52) ACP1MAPTTP53HPGDALOX15
SCHEMBL5741949 0.87 TP53 (0.49) ACP1ABCG2MAPTTP53HPGD
SCHEMBL5740501 0.86 AGPAT2 (0.52) ACP1MAPTTP53HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339706-B1 N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2006-04-19 EP disclosed